BackAdaptimmune Therapeutics Plc Overview

Adaptimmune Therapeutics Plc Other Income Expense Net

Other Income/Expense Net for ADAP.

Quarterly Other Income/Expense

$560000.00
↓ 58.13% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

-$1.82M
↓ 134.5% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin